Finland· FI-REL-REL58329

Icatibant Sandoz

A icatibant product containing icatibant acetate, registered in Finland by Sandoz A/S. The same ATC class is registered in 15 of our 19 countries.

ATC B06AC02

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedIcatibant SandozATCB06AC02REGISTER NO.FI-REL-REL58329PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Icatibant is registered in 15 of 19 countries.

Countries holding a registration under ATC B06AC02 (icatibant), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 8 of them publish a price we can compare per daily dose

Icatibant · ATC B06AC02

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Icatibant acetate
Manufacturer
Sandoz A/S
Country
Finland (FI)
ATC code
B06AC02
ATC class
Icatibant
Defined daily dose
30 mg, P
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • fi_myyntilupa
    543949
    3 ml
    EUR 138.89

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

10 interactions on record for icatibant.

Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Icatibant · interactions on record

10 records

  • 10 moderate

Most severe, free to view

  • CaptoprilC09AA01moderate
  • EnalaprilC09AA02moderate
  • LisinoprilC09AA03moderate
  • PerindoprilC09AA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Icatibant in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All icatibant products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Icatibant Hikma, Icatibant Ratiopharm®
  • Belgium · Icatibant Hikma Farmacêutica (Portugal) S.A., Icatibant Teva
  • Bulgaria · Icatibant Sandoz
  • Czechia · Icatibant Fresenius, Icatibant Universal Farma
  • Germany · Icatibant Aliud Pharma Gmbh, Icatibant Amarox
  • Denmark · Icatibant "viatris", Icatibant Adalvo
  • Estonia · Icatibant Auxilia, Icatibant Fresenius
  • Spain · Icatibanto Cipla, Icatibanto Exeltis
  • France · Icatibant Amarox, Icatibant Fresenius
  • United Kingdom (Northern Ireland) · Icatibant Amarox, Icatibant Fresenius Kabi Limited
  • Croatia · Ikatibant Alpha-Medical, Ikatibant Fresenius
  • Hungary · Icatibant Fresenius, Icatibant Stada
  • Iceland · Firazyr, Icatibant Accord
  • Italy · Icatibant, Icatibant Amarox
  • Liechtenstein · Firazyr, Icatibant Accord
  • Lithuania · Icatibant Fresenius, Idanuz
  • Latvia · Idanuz
  • Malta · Icatibant Newbury, Idisan
  • Netherlands · Icatibant Ethypharm, Icatibant Glenmark
  • Norway · Firazyr, Icatibant
  • Poland · Icatibant Universal Farma, Idanuz
  • Portugal · Icatibant Fresenius, Icatibant Hikma Farmacêutica (Portugal) S.A.
  • Romania · Icatibant Stada, Icatibant Universal Farma
  • Sweden · Icatibant Avansor, Icatibant Glenmark
  • Slovakia · Icatibant Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/047d60d2-eec2-440c-bf65-9f1adfc433e4
GET /v1/drugs/047d60d2-eec2-440c-bf65-9f1adfc433e4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "30",
  "form": "injektioneste, liuos, esitäytetty ruisku",
  "route": "Ihon alle",
  "ddd_unit": "mg",
  "strength": "30 mg",
  "atc_label": "ikatibantti",
  "ma_number": "39268",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL58329",
  "authorised_at": "2022-03-18"
}

See everything about icatibant.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.